Senti Biosciences Holdings
SNTI
27 hedge funds and large institutions have $4.15M invested in Senti Biosciences Holdings in 2024 Q1 according to their latest regulatory filings, with 7 funds opening new positions, 3 increasing their positions, 3 reducing their positions, and 5 closing their positions.
40% more first-time investments, than exits
New positions opened: 7 | Existing positions closed: 5
8% more funds holding
Funds holding: 25 → 27 (+2)
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
0% more repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 3
0.17% less ownership
Funds ownership: 2.57% → 2.4% (-0.17%)
45% less capital invested
Capital invested by funds: $7.56M → $4.15M (-$3.42M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Two Sigma Investments
New York
|
+$29K |
| 2 |
Citadel Advisors
Miami,
Florida
|
+$15.8K |
| 3 |
Renaissance Technologies
New York
|
+$10.8K |
| 4 |
VF
Virtu Financial
New York
|
+$8.8K |
| 5 |
TRCT
Tower Research Capital (TRC)
New York
|
+$3.8K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AIM
ARK Investment Management
St. Petersburg,
Florida
|
-$151K |
| 2 |
OFM
Omega Fund Management
Boston,
Massachusetts
|
-$129K |
| 3 |
AG
Artal Group
Luxembourg
|
-$37K |
| 4 |
XT
XTX Topco
George Town,
Cayman Islands
|
-$14.3K |
| 5 |
Bank of New York Mellon
New York
|
-$8.16K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
26
Comerica Bank
Dallas,
Texas
| $18 | – | – | – |
|
27
Toronto Dominion Bank
Toronto, Ontario,
Ontario, Canada
| $14 | +$18 | +4 | New |
|
|
OFM
28
Omega Fund Management
Boston,
Massachusetts
| – | -$129K | -19,579 | Closed |
|
|
AG
29
Artal Group
Luxembourg
| – | -$37K | -5,556 | Closed |
|
|
XT
30
XTX Topco
George Town,
Cayman Islands
| – | -$14.3K | -2,165 | Closed |
|
|
31
Bank of New York Mellon
New York
| – | -$8.16K | -1,237 | Closed |
|
32
JP Morgan Chase
New York
| – | -$28 | -4 | Closed |
|
SNTI Hedge Fund Activity: Q1 2024 in Review
27 of the 6,942 institutional investors tracked by Wall St. Rank reported a position in Senti Biosciences Holdings (SNTI) for Q1 2024, worth a combined $4.15M — down 45% from $7.56M a quarter earlier.
Buyers outnumbered sellers: 7 funds opened new SNTI positions and 5 closed out — a net gain of 2 holders — while 3 added to existing stakes and 3 trimmed.
The largest buyer was Two Sigma Investments, adding an estimated $29K. The largest seller was ARK Investment Management, cutting an estimated $151K.
- 27 institutional investors held Senti Biosciences Holdings (SNTI) as of Q1 2024, up from 25 in Q4 2023.
- Funds reported $4.15M of Senti Biosciences Holdings stock for Q1 2024, down 45% quarter-over-quarter.
- 7 funds opened new Senti Biosciences Holdings positions in Q1 2024 and 5 closed out, a net change of +2 holders.
- The largest Senti Biosciences Holdings buyer in Q1 2024 was Two Sigma Investments, an estimated $29K added.
- The largest Senti Biosciences Holdings seller in Q1 2024 was ARK Investment Management, an estimated $151K sold.
Based on aggregated 13F filings for Q1 2024.